相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Similarity of Response to Biologics Between Elderly-onset Rheumatoid Arthritis (EORA) and Non-EORA Elderly Patients: From the FIRST Registry
Sae Ochi et al.
JOURNAL OF RHEUMATOLOGY (2021)
Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
Yusuke Miyazaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases
Yuichi Ishikawa et al.
RMD OPEN (2021)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry
Akio Kawabe et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
Sae Ochi et al.
ARTHRITIS RESEARCH & THERAPY (2020)
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary
Christopher R. Holroyd et al.
RHEUMATOLOGY (2019)
Diagnosis and Management of Pneumocystis Pneumonia in Resource-poor Settings
Rita O. Oladele et al.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2018)
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
Masako Utsunomiya et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching
Satoshi Kubo et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
K. L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
Masayoshi Harigai et al.
MODERN RHEUMATOLOGY (2016)
Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor a: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Ellen S. Bruce et al.
RHEUMATOLOGY (2016)
Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Ellen S. Bruce et al.
RHEUMATOLOGY (2016)
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
Jasvinder A. Singh et al.
LANCET (2015)
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
John W. Baddley et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Takao Koike et al.
Modern Rheumatology (2014)
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
Takayuki Katsuyama et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
Takao Koike et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
T. Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases:: re-evaluation of clinical features of P-carinii pneumonia in rheumatic diseases
K Saito et al.
RHEUMATOLOGY (2004)
Pneumocystis pneumonia
CF Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
